Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8351174 | 0.96 | TSHR (0.41) | TSHRTP53ALDH1A1LMNATHRB | |
| SCHEMBL8346659 | 0.96 | TSHR (0.41) | TSHRTP53ALDH1A1LMNATHRB | |
| Ammonia Solution, Strong SCHEMBL714830 | 0.96 | TSHR (0.41) | TSHRTP53ALDH1A1LMNATHRB | |
| Ammonia Solution, Strong SCHEMBL8353342 | 0.96 | TSHR (0.41) | TSHRTP53ALDH1A1LMNATHRB | |
| SCHEMBL3677211 | 0.86 | TSHR (0.39) | TSHRTP53ALDH1A1LMNATHRB | |
| SCHEMBL3690907 | 0.86 | TSHR (0.39) | TSHRTP53ALDH1A1LMNATHRB | |
| SCHEMBL6045961 | 0.83 | TSHR (0.32) | TSHRTP53 | |
| Monoethanolamine SCHEMBL1964143 | 0.81 | TSHR (0.40) | TSHRALDH1A1LMNAOR51E2 | |
| SCHEMBL41377 | 0.77 | TSHR (0.44) | TSHRTP53ALDH1A1LMNATHRB | |
| Ammonia Solution, Strong SCHEMBL246433 | 0.74 | TSHR (0.41) | TSHRTP53ALDH1A1LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099320-A1 | TERPOLYMER COMPOSITIONS, METHODS FOR THEIR PREPARATION, AND THEIR USE FOR SEPARATING MINERALS | CYTEC INDUSTRIES INC. (US) | 2026-05-15 | — | — | WO | claimed |
| EP-4505000-B1 | ELECTROLYTE COMPRISING AN ACCELERATOR AGENT FOR BOTTOM-UP COPPER ELECTROPLATING | MACDERMID ENTHONE INC (US) | 2025-12-24 | — | — | EP | claimed |
| US-12419551-B2 | Mediation of in vivo analyte signal degradation | SENSEONICS, INCORPORATED (US) | 2025-09-23 | — | — | US | claimed |
| EP-4590782-A1 | GAS-PHASE COMPOSITION FOR INHIBITING CORROSION EXPOSED TO CONDENSED WATER | Arkema France (FR) | 2025-07-30 | — | — | EP | claimed |
| CN-119970792-A | Bimetal nanoparticle and preparation method and application thereof | 南方医科大学 | 2025-05-13 | — | — | CN | claimed |
| WO-2025096734-A1 | MICROCAPSULES | FMC CORPORATION (US) | 2025-05-08 | — | — | WO | claimed |
| US-20250137157-A1 | ELECTROLYTE COMPRISING AN ACCELERATOR AGENT FOR BOTTOM-UP COPPER ELECTROPLATING | MACDERMID ENTHONE INC (US) | 2025-05-01 | — | — | US | claimed |
| WO-2025074986-A1 | MODIFIED POLYCARBONATE, METHOD FOR PRODUCING MODIFIED POLYCARBONATE, AND RESIN COMPOSITION | 株式会社カネカ | 2025-04-10 | — | — | WO | claimed |
| EP-3965657-B1 | MEDIATION OF IN VIVO ANALYTE SIGNAL DEGRADATION | SENSEONICS INC (US) | 2025-03-05 | — | — | EP | claimed |
| EP-4505000-A1 | ELECTROLYTE COMPRISING AN ACCELERATOR AGENT FOR BOTTOM-UP COPPER ELECTROPLATING | MacDermid Enthone Inc. (US) | 2025-02-12 | — | — | EP | claimed |
| EP-0058044-B1 | ELECTRODEPOSITION OF CHROMIUM | W. CANNING MATERIALS LIMITED (GB) | 1986-06-18 | — | — | EP | claimed |
| US-4529712-A | Amino reactive end of a heterobifunctional crosslinking reagent connects to thiol reactive compound | RESEARCH CORPORATION (US) | 1985-07-16 | — | — | US | claimed |
| US-4473448-A | Electrodeposition of chromium | W. CANNING MATERIALS LIMITED (GB) | 1984-09-25 | — | — | US | claimed |
| US-4463082-A | CARBOXY-CONTAINING MERCAPTAN AND DISULFIDES TO INCREASE SHELF LIFE OF SELF-DEVELOPING COLOR FILMS | POLAROID CORPORATION (US) | 1984-07-31 | — | — | US | claimed |
| US-4391286-A | QUATERNARY NITROGEN POLYMER AND A DISULFIDE POLYCARBOXYLIC ACID | HELENE CURTIS INDUSTRIES (US) | 1983-07-05 | — | — | US | claimed |
| EP-0058044-A1 | Electrodeposition of chromium | W. CANNING MATERIALS LIMITED (GB) | 1982-08-18 | — | — | EP | claimed |
| US-4273143-A | Permanent wave composition | ZOTOS INTERNATIONAL, INC. (US) | 1981-06-16 | — | — | US | claimed |
| US-4218327-A | BY DEOXYGENATION; FLOW CONTROL AGENTS FOR ENHANCED OIL RECOVERY | SHELL OIL COMPANY (US) | 1980-08-19 | — | — | US | claimed |
| US-3959149-A | Isocyanate resin absorbent for free chlorine, heavy metals and heavy metallic compounds | NIPPON SODA COMPANY LIMITED (JA) | 1976-05-25 | — | — | US | claimed |
| US-3947292-A | Preparation of an alkaline iron electrode material using sulfur acids | WESTINGHOUSE ELECTRIC CORPORATION (US) | 1976-03-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12419551-B2 | Mediation of in vivo analyte signal degradation | SLC2A1, TXN2, SLC2A8 | TSHR 1204/4885TP53 1139/4885ALDH1A1 323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.